Cross-species transcriptomic integration reveals a MIRO1-mediated macrophage–T cell axis in glioma
Life Science Alliance · 2026-08 · 9 (8) · e202603749
DOI: 10.26508/lsa.202603749 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Science Alliance, online erschienen am 13.05.2026. Verfasst von Zehui Du und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA, USA. Hauptthemen laut MEDLINE: Glioma, Macrophages, Transcriptome, Mitochondrial Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NINDS NIH HHS, HHS | NIH | National Institute of Neurological Disorders and Stroke.
Abstract (Originalsprache)
Mitochondrial regulators are increasingly recognized for their influence on immune signaling within the tumor microenvironment (TME). In glioma, where immunosuppression limits therapeutic efficacy, we investigate how targeting the mitochondrial protein MIRO1 alters the TME. We combine single-nucleus RNA sequencing of murine gliomas treated in vivo with an MIRO1-binding compound and bulk RNA sequencing of human glioma resections treated with the same compound ex vivo. Cross-species transcriptomic integration reveals an MIRO1-responsive program in the TME. Among shared targets, we identify PARP11/Parp11 as a consistently up-regulated gene in glioma, which is down-regulated after MIRO1-binding compound treatment in both human and mouse gliomas. Cell–cell communication analysis shows that a specific cluster of macrophages (MAC1), which exhibits robust Parp11 and Pdl1 (encoding PD-L1) expression, sends immunosuppressive signals to CD8 + cytotoxic T cells, and may receive prostaglandin E 2 signals from another cluster of macrophages (MAC4). Targeting MIRO1 eliminates this cell circuitry and reduces the tumor cell population. Our study provides a transcriptomic framework for understanding mitochondria-immune crosstalk and nominates MIRO1-PARP11 as a potential effector axis of brain immune dysfunction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA, USA.
- Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA.
- The Phil and Penny Knight Initiative for Brain Resilience, Stanford University, Stanford, CA, USA.
- Wu Tsai Neurosciences Institute, Stanford University, Stanford, CA, USA.
- Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA, USA xinnanw@stanford.edu.
ORCID-Profile: Zehui Du, Menghan Li, Brandon H Bergsneider, Tony Wyss-Coray, Xinnan Wang
Förderung
- NIGMS NIH HHS
- NINDS NIH HHS
- HHS | NIH | National Institute of Neurological Disorders and Stroke
- HHS | NIH | National Institute of General Medical Sciences
- Stanford Wu Tsai Neurosciences Institute
Zitieren
APA
Du, Z., Li, M., Bergsneider, B. H., Tsai, A. P., Cho, K. B., Kim, L. H., Choi, J., Li, G., Wyss-Coray, T., Lim, M., & Wang, X. (2026). Cross-species transcriptomic integration reveals a MIRO1-mediated macrophage–T cell axis in glioma. Life Science Alliance, 9(8), e202603749. https://doi.org/10.26508/lsa.202603749
Vancouver
Du Z, Li M, Bergsneider BH, Tsai AP, Cho KB, Kim LH, et al. Cross-species transcriptomic integration reveals a MIRO1-mediated macrophage–T cell axis in glioma. Life Science Alliance. 2026;9(8):e202603749. doi:10.26508/lsa.202603749
BibTeX
@article{Du2026,
author = {Du, Zehui and Li, Menghan and Bergsneider, Brandon H and Tsai, Andy P and Cho, Kwang Bog and Kim, Lily H and Choi, John and Li, Gordon and Wyss-Coray, Tony and Lim, Michael and Wang, Xinnan},
title = {Cross-species transcriptomic integration reveals a MIRO1-mediated macrophage–T cell axis in glioma},
journal = {Life Science Alliance},
year = {2026},
volume = {9},
number = {8},
pages = {e202603749},
doi = {10.26508/lsa.202603749}
}
EUVIMED